Immune Cell Trafficking

B01

Immune regulation at the CNS barriers and in the CNS:
role of immune cell trafficking

Univ.-Prof. Dr. rer. nat. Nicholas Schwab
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster

Prof. Dr. med. Alexander Zarbock
Klinik für Anästhesiologie und Intensivmedizin
Münster

 

B03

Molecular mechanisms and sites of action of the gelatinases in
autoimmune CNS inflamma-tion: do MMP-2/-9 contribute to meningeal inflammation and secondary cortical damage?

Univ.-Prof. Dr. rer. nat. Lydia Sorokin
Institut für Physiologische Chemie und Pathobiochemie
Münster

Priv.-Doz. Dr. med. Gerd Meyer zu Hörste
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster

 

B15

Spatiotemporal effects of IL-4 and designed novel compounds on CNS repair during neuroinflammation

Dr. rer. nat. Christina Francisca Vogelaar
Klinik für Neurologie
Mainz

Univ.-Prof. Dr. med. Frauke Zipp
Klinik für Neurologie, Forschungszentrum Immuntherapie
Mainz

News

Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more
Wed, 20/01/2021
A new study on neurological manifestations of severe COVID-19 reveals nervous system immune deficiency
Patients suffering from COVID-19 can develop concomitant and long-term symptoms in their nervous system. The most common symptom in this context is the loss of the sense of smell and taste, while more severe symptoms such as stroke, cerebral seizures, or meningitis are possible. A team of scientists from the medical faculties at the Universities […]...more
Fri, 15/01/2021
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
It has long been acknowledged that multiple sclerosis disease risk is associated with reduced sun-exposure, and subsequent low vitamin D levels. The study by Ostkamp et al. now assessed the relationship between measures of sun exposure and MS severity. For this, the researchers analyzed data of around 2,000 patients from the German NationMS- and the […]...more